(Q34074333)

30 July 2017

1 reference

title

The anti-inflammatory profile of inhaled corticosteroids combined with salmeterol in asthmatic patients (English)

1 reference

30 July 2017

0 references

2

Bjermer L

1 reference

30 July 2017

Walters EH

1

1 reference

30 July 2017

Faurschou P

series ordinal

3

1 reference

30 July 2017

Sandström T

series ordinal

4

1 reference

30 July 2017

publication date

1 October 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

94 Suppl F

1 reference

30 July 2017

page(s)

S26-31

1 reference

Damage of the airway epithelium and bronchial reactivity in patients with asthma

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Mucosal inflammation in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Cellular events in the bronchi in mild asthma and after bronchial provocation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Worldwide differences in asthma prevalence and mortality. Why is asthma mortality so low in the USA?

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

The lack of distensibility of asthmatic airways

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Efficacy and safety of inhaled corticosteroids in asthma. Report of a workshop held in Eze, France, October 1992.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Salmeterol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

An antiinflammatory effect of salmeterol, a long-acting beta(2) agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Workshop summary and guidelines: investigative use of bronchoscopy, lavage, and bronchial biopsies in asthma and other airway diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Bronchoscopic evaluation of severe asthma. Persistent inflammation associated with high dose glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Bronchial vascular engorgement and airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Increased vascularity of the bronchial mucosa in mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Vascularity in asthmatic airways: relation to inhaled steroid dose

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Macrophages cultured in vitro release leukotriene B4 and neutrophil attractant/activation protein (interleukin 8) sequentially in response to stimulation with lipopolysaccharide and zymosan

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Bronchial hyperresponsiveness and airway neutrophil accumulation induced by interleukin-8 and the effect of the thromboxane A2 antagonist S-1452 in guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Secretion of chemokines and other cytokines in allergen-induced nasal responses: inhibition by topical steroid treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Interleukin-8 as a macrophage-derived mediator of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Systemic oxidative stress in asthma, COPD, and smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Bronchiolitis obliterans syndrome in lung transplant recipients is associated with increased neutrophil activity and decreased antioxidant status in the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Reactive oxygen species and airway inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Salmeterol reduces early- and late-phase plasma leakage and leukocyte adhesion in rat airways

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Glucocorticoids induce beta2-adrenergic receptor function in human nasal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2800%2990130-6

7 January 2021

10.1016/S0954-6111(00)90130-6

Identifiers

DOI

1 reference

30 July 2017

1 reference